Accurexa Inc. Common Stock (OB:ACXA)
Business Focus: N/A
Jan 20, 2017 05:30 pm ET
"New to the Street" Broadcasting on Fox Business Network January 22, 2017 @ 1:30 PM ET / 10:30AM PT Featuring XFit Brands, Inc. (XFIT)
"New to the Street" TV announces the airing this Sunday, January 22, 2017, at 1:30 ET/10:30 PT on Fox Business Network featuring XFit Brands, Inc. (OTCQB: XFTB)"New To The Street" TV's host Ken Evseroff, in a 30-minute in-depth interview, learns...
Nov 28, 2016 02:00 pm ET
ACCUREXA, INC. (ACXA) and Other Medical Device Companies Add Value for Patients and Investors
Accurexa, Inc. (OTCQB: ACXA), a small-cap biotech focused on chemotherapy and immunology, is an up-and-coming leader in the neurological therapy space. Currently, Accurexa is working on the targeted delivery of such therapies, specifically the...
Oct 25, 2016 03:15 pm ET
"NEW TO THE STREET" Broadcasting on FOX Business, October 30, 2016, 1 PM Featuring -- Accurex, Inc. (ACXA), Oakridge Global Energy Solutions, Inc. (OGES), International Western Petroleum (INWP), Funda
"NEW TO THE STREET" announces its Sunday, October 30, 2016, at 1:00 PM show. Broadcasting on FOX Business Network, "NEW TO THE STREET" interviews Accurexa, Inc. (OTCQB: ACXA), Oakridge Global Energy Solutions, Inc. (OTCQB: OGES), International...
Oct 03, 2016 02:24 pm ET
"NEW TO THE STREET's" October Line-Up Broadcast on FOX Business -- Accurexa (ACXA) Oakridge Global Energy Solutions (OGES), Fundamental Applications Corp. (FUAPF), International Western Petroleum (INW
"NEW TO THE STREET" announces its Sunday, October 23, 2016, at 1:30 PM show. Broadcasting on FOX Business Network, "NEW TO THE STREET" interviews Accurexa, Inc. (OTCQB: ACXA), Oakridge Global Energy Solutions, Inc. (OTCQB: OGES), Fundamental...
Sep 07, 2016 09:30 am ET
DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer
VANCOUVER, British Columbia and WALNUT CREEK, Calif., Sept. 7, 2016 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar"), a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, and Accurexa Inc. (OTCQB: ACXA) ("Accurexa"), a company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today a collaboration to develop a novel formulation for the local delivery of combination chemotherapy for the treatment of brain cancer and other solid tumors.
Jun 09, 2016 02:26 pm ET
"New To The Street" Showcasing Fundamental Application Corporation (FUAPF) in a 6 Part National T.V. Series
"New To The Street" to shoot first interview with Fundamental Applications Corp. (OTCQB: FUAPF) in 6 part National T.V. Series, showcasing their hot apps. "New To The Street" will interview Bradley Moore C.E.O. on the FAUPF's current app products...
Apr 26, 2016 06:30 pm ET
"New To The Street" to Broadcast 4/27/2016 to the NY #1 Market on WPXN 7AM
"New To The Street" will be broadcasting its latest show, on New York City's WPXN-TV at 7AM ET, April 27, 2016.
The Companies being interviewed are:
-
Accurexa, Inc.'s
(OTCQB: ACXA)
CEO, George Yu speaks about their...
Jan 26, 2016 11:31 am ET
"New To The Street" Brings on New Companies for 2016 and Updates on Existing Companies
"New To The Street" looks forward to its continued monthly series with the first 2016 season taping set for January 27, 2016. This series features the following:- Momentous Entertainment Group; (OTC PINK: MMEG)- Green Polka Dot Box; (OTC PINK:...
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.